Stadler WM - Search Results

1

Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.

Rini BI, Wilding G, Hudes G, Stadler WM, Kim S, Tarazi J, Rosbrook B, Trask PC, Wood L, Dutcher JP. Rini BI, et al. Among authors: stadler wm. J Clin Oncol. 2009 Sep 20;27(27):4462-8. doi: 10.1200/JCO.2008.21.7034. Epub 2009 Aug 3. J Clin Oncol. 2009. PMID: 19652060 Clinical Trial.

2

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.

Stadler WM, Kuzel T, Roth B, Raghavan D, Dorr FA. Stadler WM, et al. J Clin Oncol. 1997 Nov;15(11):3394-8. doi: 10.1200/JCO.1997.15.11.3394. J Clin Oncol. 1997. PMID: 9363871 Clinical Trial.

3

Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trial.

Rini BI, Stadler WM, Spielberger RT, Ratain MJ, Vogelzang NJ. Rini BI, et al. Among authors: stadler wm. Cancer. 1998 Apr 1;82(7):1352-8. doi: 10.1002/(sici)1097-0142(19980401)82:7<1352::aid-cncr19>3.0.co;2-5. Cancer. 1998. PMID: 9529028 Clinical Trial.

4

Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma.

Stadler WM, Kuzel T, Dumas M, Vogelzang NJ. Stadler WM, et al. J Clin Oncol. 1998 May;16(5):1820-5. doi: 10.1200/JCO.1998.16.5.1820. J Clin Oncol. 1998. PMID: 9586896 Clinical Trial.

5

Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma.

Stadler WM, Kuzel T, Shapiro C, Sosman J, Clark J, Vogelzang NJ. Stadler WM, et al. J Clin Oncol. 1999 Aug;17(8):2541-5. doi: 10.1200/JCO.1999.17.8.2541. J Clin Oncol. 1999. PMID: 10561320 Clinical Trial.

6

Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study.

Stadler WM, Vogelzang NJ, Amato R, Sosman J, Taber D, Liebowitz D, Vokes EE. Stadler WM, et al. J Clin Oncol. 2000 Jan;18(2):371-5. doi: 10.1200/JCO.2000.18.2.371. J Clin Oncol. 2000. PMID: 10637252 Clinical Trial.

7

Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.

Kaufman D, Raghavan D, Carducci M, Levine EG, Murphy B, Aisner J, Kuzel T, Nicol S, Oh W, Stadler W. Kaufman D, et al. J Clin Oncol. 2000 May;18(9):1921-7. doi: 10.1200/JCO.2000.18.9.1921. J Clin Oncol. 2000. PMID: 10784633 Clinical Trial.

8

Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer.

Rini BI, Vogelzang NJ, Dumas MC, Wade JL 3rd, Taber DA, Stadler WM. Rini BI, et al. Among authors: stadler wm. J Clin Oncol. 2000 Jun;18(12):2419-26. doi: 10.1200/JCO.2000.18.12.2419. J Clin Oncol. 2000. PMID: 10856102 Clinical Trial.

9

Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma.

Rini BI, Zimmerman TM, Gajewski TF, Stadler WM, Vogelzang NJ. Rini BI, et al. Among authors: stadler wm. J Urol. 2001 Apr;165(4):1208-9. J Urol. 2001. PMID: 11257677 No abstract available.

10

A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma.

George CM, Vogelzang NJ, Rini BI, Geoffroy FJ, Kollipara P, Stadler WM. George CM, et al. Among authors: stadler wm. Ann Oncol. 2002 Jan;13(1):116-20. doi: 10.1093/annonc/mdf008. Ann Oncol. 2002. PMID: 11863091 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters